
Amarin Corp Plc
AMRNCompany News
Recordati reported strong financial performance in Q3 2025, with revenue up 12.2% to €1,956.2 million, driven by growth in Rare Diseases and Specialty & Primary Care segments. The company doubled its peak sales estimate for Isturisa to over €1.2 billion and expects Rare Diseases to approach 50% of total revenues in 2026.
Kymera (KYMR) reports a narrower-than-expected loss in the first quarter. The company expects the current cash balance to provide a runway into the first half of 2027.
AMRN earnings call for the period ending March 31, 2024.
Shares of Butterfly Network, Inc. (NASDAQ: BFLY) fell sharply during Thursday’s session after the company reported mixed fourth-quarter financial results. Butterfly Network posted GAAP loss of 21 cents per share versus market estimates for a loss of 14 cents per share. The company’s quarterly sales came in at sales came in $16.52 million ve...


